$2.60 EPS Expected for Molina Healthcare, Inc. (NYSE:MOH) This Quarter

Wall Street analysts expect that Molina Healthcare, Inc. (NYSE:MOH) will report earnings of $2.60 per share for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Molina Healthcare’s earnings, with estimates ranging from $2.52 to $2.70. Molina Healthcare posted earnings of $3.88 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 33%. The business is expected to report its next quarterly earnings report on Monday, February 10th.

On average, analysts expect that Molina Healthcare will report full year earnings of $11.55 per share for the current fiscal year, with EPS estimates ranging from $11.48 to $11.65. For the next financial year, analysts forecast that the business will report earnings of $11.85 per share, with EPS estimates ranging from $11.49 to $12.13. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow Molina Healthcare.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $2.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.70 by $0.10. Molina Healthcare had a return on equity of 49.14% and a net margin of 4.47%. The business had revenue of $4.24 billion for the quarter, compared to analyst estimates of $4.15 billion. During the same quarter in the previous year, the firm earned $2.97 EPS. Molina Healthcare’s quarterly revenue was down 9.7% on a year-over-year basis.

Several equities research analysts have recently commented on the stock. Jefferies Financial Group downgraded shares of Molina Healthcare from a “buy” rating to a “hold” rating and reduced their target price for the company from $133.00 to $120.00 in a research note on Wednesday, October 30th. Deutsche Bank assumed coverage on shares of Molina Healthcare in a research report on Thursday, September 12th. They set a “buy” rating and a $145.00 target price for the company. ValuEngine raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Friday, November 29th. Finally, Morgan Stanley reduced their price target on shares of Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating on the stock in a research report on Friday, August 23rd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company’s stock. Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $155.89.

In other news, Director Ronna Romney sold 375 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $121.97, for a total transaction of $45,738.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Dale B. Wolf sold 3,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $135.51, for a total transaction of $474,285.00. Following the sale, the director now directly owns 8,461 shares in the company, valued at $1,146,550.11. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the stock. FinTrust Capital Advisors LLC bought a new position in Molina Healthcare in the 3rd quarter valued at $26,000. Advisors Preferred LLC bought a new stake in shares of Molina Healthcare during the second quarter worth $37,000. Endurance Wealth Management Inc. bought a new stake in shares of Molina Healthcare during the third quarter worth $44,000. Stonebridge Capital Advisors LLC bought a new stake in shares of Molina Healthcare during the second quarter worth $57,000. Finally, Financial Gravity Wealth Inc. lifted its stake in shares of Molina Healthcare by 35.0% during the second quarter. Financial Gravity Wealth Inc. now owns 501 shares of the company’s stock valued at $72,000 after acquiring an additional 130 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Shares of NYSE MOH traded up $0.81 during midday trading on Tuesday, reaching $133.30. 408,700 shares of the company traded hands, compared to its average volume of 471,579. The firm has a market cap of $8.31 billion, a PE ratio of 12.03, a PEG ratio of 1.22 and a beta of 1.16. The stock’s 50-day simple moving average is $127.53 and its 200-day simple moving average is $130.84. Molina Healthcare has a 12 month low of $105.28 and a 12 month high of $159.00. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.78 and a current ratio of 1.78.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Further Reading: What are the Benefits of Index Funds?

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.